Clinical Trial Update: Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating switching from insulin to a sulfonylurea in diabetes associated with MODY gene variants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Diabetes Mellitus
• Insulin-dependent Diabetes Mellitus
• Maturity-onset Diabetes of the Young Type 1
• Maturity-onset Diabetes of the Young Type 3

Drugs mentioned

• Insulin (insulin)
• Sulfonylurea (sulfonylurea)

Snippet

Sponsor: Haukeland University Hospital | Conditions: Maturity-Onset Diabetes of the Young, Type 3, Maturity Onset Diabetes of the Young, Type 1 | Phase 4 | Status: UNKNOWN